Merck & Co., Inc. (MRK) Stock Score, Valuation & Financial Research
Merck & Co., Inc. is in the Healthcare sector and Drug Manufacturers - General industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 35/100.
Quick answer for MRK
Merck & Co., Inc. currently has a Wall Street Score of 35/100. The stored market price is $143.94. Its financial score is 24/100. Its valuation score is 19/100. The latest WSS change is -0.1 points. These figures are a research snapshot, not a buy or sell recommendation.
What Merck & Co., Inc. does
Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, ho
MRK financial snapshot
- Wall Street Score:
- 35/100
- Current price:
- $143.94
- Market capitalization:
- $355.49B
- Revenue:
- $65.59B
- Net income:
- $8.94B
- Free cash flow:
- $12.36B
- Cash:
- $5.33B
- Total debt:
- $49.12B
- EPS:
- 7.30
- P/E ratio:
- 19.7x
- Financial score:
- 24/100
- Valuation score:
- 19/100
- Revenue score:
- 14/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $12.36B, showing positive cash generation.
- The balance sheet shows $5.33B of cash versus $49.12B of total debt, so leverage deserves attention.
- The latest Wall Street Score change is -0.1 points: MRK decreased 0.1 points because some fundamentals weakened.
What the numbers mean
Its current valuation score is 19/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 24/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research MRK
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.